Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
UK-based digital therapy company focused on mental disorders.
Big Health is a digital therapeutics company dedicated to helping millions back to good mental health. Its first digital therapeutics Sleepio, for poor sleep and Daylight, for worry and anxiety are fully automated, scalable cognitive and behavioural programs. Big Health’s products are backed by 50 published clinical papers including 13 randomised controlled trials (RCTs), and are cited in leading clinical guidelines including the American College of Physicians and NICE. Today, over 12 million people worldwide have reimbursed access to Big Health’s products, via leading employers in the US and the UK’s NHS.
More Big Health news
Gilde Healthcare company Big Health expands into adolescent mental health through acquisition of Limbix
Gilde Healthcare company Big Health builds out its Leadership Team with the appointment of five key Executives
Gilde Healthcare company Big Health receives NICE digital therapeutics guidance confirming clinical and cost effectiveness
Gilde Healthcare Portfolio Company Big Health Adds Former FDA Deputy Commissioner Anand Shah to Its Board of Directors
Gilde Healthcare Portfolio Company Big Health Raises $75 Million in Series C Funding
Gilde Healthcare leads $39 million in Series B financing in Big Health
Venture&Growth
Purespring Therapeutics
Founded in 2020, Purespring is a pioneering London (UK)-based gene therapy company focused on transforming treatments for patients suffering from chronic kidney diseases. It is the first company to successfully treat kidney disease by targeting the podocyte, a specialised cell

Venture&Growth
Shoulder Innovations
Shoulder Innovations is a US-based medical device company that is commercializing a novel shoulder arthroplasty portfolio paired with an AI-enabled surgical planning software. The portfolio is anchored by Shoulder Innovations’ proprietary InSetTM glenoid fixing technology to solve the problem of

Venture&Growth
Karius, Inc.
Karius is a U.S.-based diagnostic company that develops and commercializes an AI-based liquid biopsy test to diagnose serious infections in immunocompromised patients and other hospitalized patients. The company is commercial in the U.S. and provides strong potential for better care
